Overview
Sachin Khurana practices in New Delhi, India. Mr. Khurana is rated as an Experienced expert by MediFind in the treatment of Metastatic Brain Tumor. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Lung Adenocarcinoma, and Tissue Biopsy.
His clinical research consists of co-authoring 38 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Metastatic Brain Tumor.
Locations
Delhi, DL, India
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lung CancerMr. Khurana isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Mr. Khurana isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Tissue BiopsyMr. Khurana isAdvanced. Learn about Tissue Biopsy.
- Experienced
- Brain TumorMr. Khurana isExperienced. Learn about Brain Tumor.
- EGFR Positive Lung CancerMr. Khurana isExperienced. Learn about EGFR Positive Lung Cancer.
- Endometrial Stromal SarcomaMr. Khurana isExperienced. Learn about Endometrial Stromal Sarcoma.
- Gestational Trophoblastic DiseaseMr. Khurana isExperienced. Learn about Gestational Trophoblastic Disease.
- Infantile NeutropeniaMr. Khurana isExperienced. Learn about Infantile Neutropenia.
- Lung AdenocarcinomaMr. Khurana isExperienced. Learn about Lung Adenocarcinoma.